Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
NCT ID: NCT00225524
Last Updated: 2007-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
150 participants
INTERVENTIONAL
2004-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Effexor XR
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with history or presence of bipolar disorder
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wyeth is now a wholly owned subsidiary of Pfizer
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Medical Monitor
Role: STUDY_DIRECTOR
Wyeth is now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nagoya, Aichi-ken, Japan
Nagoya, Aichi-ken, Japan
Ichikawa, Chiba, Japan
Ichikawa, Chiba, Japan
Fukuoka, Fukuoka, Japan
Fukuoka, Fukuoka, Japan
Fukuoka, Fukuoka, Japan
Fukuoka, Fukuoka, Japan
Kasuga, Fukuoka, Japan
Kitakyushu, Fukuoka, Japan
Kitakyushu, Fukuoka, Japan
Kitakyushu, Fukuoka, Japan
Kurume, Fukuoka, Japan
Ohnojyo, Fukuoka, Japan
Hiroshima, Hiroshima, Japan
Hiroshima, Hiroshima, Japan
Hiroshima, Hiroshima, Japan
Kure, Hiroshima, Japan
Otaru, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Sapporo, Hokkaido, Japan
Nishinomiya, Hyōgo, Japan
Tsuchiura, Ibaragi, Japan
Tsukuba, Ibaragi, Japan
Kanazawa, Ishikawa-ken, Japan
Hanamaki, Iwate, Japan
Kawasaki, Kanagawa, Japan
Kawasaki, Kanagawa, Japan
Sagamihara, Kanagawa, Japan
Sagamihara, Kanagawa, Japan
Yokohama, Kanagawa, Japan
Yokohama, Kanagawa, Japan
Yokohama, Kanagawa, Japan
Yokohama, Kanagawa, Japan
Yokohama, Kanagawa, Japan
Yokohama, Kanagawa, Japan
Yokosuka, Kanagawa, Japan
Kikuchi, Kumamoto, Japan
Nagasaki, Nagasaki, Japan
Ohmura, Nagasaki, Japan
Kashihara, Nara, Japan
Jyo-etsu, Niigata, Japan
Beppu, Ohita, Japan
Moriguchi, Osaka, Japan
Osaka, Osaka, Japan
Osaka, Osaka, Japan
Sayama, Osaka, Japan
Sayama, Osaka, Japan
Saitama, Saitama, Japan
Hamamatsu, Shizuoka, Japan
Adachi-ku, Tokyo, Japan
Bunkyo-ku, Tokyo, Japan
Bunkyo-ku, Tokyo, Japan
Chiyoda-ku, Tokyo, Japan
Chiyoda-ku, Tokyo, Japan
Itabashi-ku, Tokyo, Japan
Kodaira, Tokyo, Japan
Meguro-ku, Tokyo, Japan
Meguro-ku, Tokyo, Japan
Meguro-ku, Tokyo, Japan
Minato-ku, Tokyo, Japan
Minato-ku, Tokyo, Japan
Nakano-ku, Tokyo, Japan
Ohta-ku, Tokyo, Japan
Setagaya-ku, Tokyo, Japan
Shinjuku, Tokyo, Japan
Tachikawa, Tokyo, Japan
Toshima-ku, Tokyo, Japan
Toshima-ku, Tokyo, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0600B1-818
Identifier Type: -
Identifier Source: org_study_id